![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MedAlliance Earns CE Mark for Drug-Eluting Balloon
MedAlliance Earns CE Mark for Drug-Eluting Balloon
MedAlliance has received CE mark certification for its Selution SLR 014 PTCA, a sirolimus drug-eluting balloon for treating patients with coronary arterial disease.
Sirolimus is an immunosuppressive drug frequently used to prevent organ rejection after a kidney transplant. The new certification is for treatment of lesions and in-stent restenosis.
The drug-eluting balloon uses “micro reservoirs” composed of biodegradable polymer that is mixed with the drug to control its release.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct